1. Home
  2. NG vs DVAX Comparison

NG vs DVAX Comparison

Compare NG & DVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NG
  • DVAX
  • Stock Information
  • Founded
  • NG 1984
  • DVAX 1996
  • Country
  • NG Canada
  • DVAX United States
  • Employees
  • NG N/A
  • DVAX N/A
  • Industry
  • NG Precious Metals
  • DVAX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NG Basic Materials
  • DVAX Health Care
  • Exchange
  • NG Nasdaq
  • DVAX Nasdaq
  • Market Cap
  • NG 1.5B
  • DVAX 1.3B
  • IPO Year
  • NG N/A
  • DVAX 2004
  • Fundamental
  • Price
  • NG $6.76
  • DVAX $10.06
  • Analyst Decision
  • NG Strong Buy
  • DVAX Buy
  • Analyst Count
  • NG 2
  • DVAX 4
  • Target Price
  • NG $7.00
  • DVAX $26.50
  • AVG Volume (30 Days)
  • NG 3.2M
  • DVAX 2.0M
  • Earning Date
  • NG 10-01-2025
  • DVAX 11-06-2025
  • Dividend Yield
  • NG N/A
  • DVAX N/A
  • EPS Growth
  • NG N/A
  • DVAX N/A
  • EPS
  • NG N/A
  • DVAX N/A
  • Revenue
  • NG N/A
  • DVAX $316,268,000.00
  • Revenue This Year
  • NG N/A
  • DVAX $23.23
  • Revenue Next Year
  • NG N/A
  • DVAX $16.57
  • P/E Ratio
  • NG N/A
  • DVAX N/A
  • Revenue Growth
  • NG N/A
  • DVAX 26.66
  • 52 Week Low
  • NG $2.26
  • DVAX $9.22
  • 52 Week High
  • NG $6.95
  • DVAX $14.63
  • Technical
  • Relative Strength Index (RSI)
  • NG 71.73
  • DVAX 41.42
  • Support Level
  • NG $6.56
  • DVAX $10.27
  • Resistance Level
  • NG $6.95
  • DVAX $10.28
  • Average True Range (ATR)
  • NG 0.26
  • DVAX 0.32
  • MACD
  • NG 0.02
  • DVAX -0.06
  • Stochastic Oscillator
  • NG 82.89
  • DVAX 17.26

About NG Novagold Resources Inc.

Novagold Resources Inc operates in the gold mining industry, focused on advancing the Donlin Gold project in Alaska. The Donlin Gold project is held by Donlin Gold LLC (Donlin Gold), a limited liability company owned equally by wholly owned subsidiaries of NOVAGOLD and Barrick Gold Corporation (Barrick). The company includes exploration and development activities of gold and other presious metals.

About DVAX Dynavax Technologies Corporation

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Share on Social Networks: